{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:41:27Z","timestamp":1793047287382,"version":"4.5.0"},"reference-count":156,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Heilongjiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LH2019C043"],"award-info":[{"award-number":["LH2019C043"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970651"],"award-info":[{"award-number":["31970651"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12026414"],"award-info":[{"award-number":["12026414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.csbj.2024.03.026","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T14:56:12Z","timestamp":1711637772000},"page":"1348-1363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The molecular subtypes of autoimmune diseases"],"prefix":"10.34133","volume":"23","author":[{"given":"Xiangshu","family":"Cheng","sequence":"first","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Meng","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerun","family":"Song","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wei","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchao","family":"Lv","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhao","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongshuai","family":"Jiang","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","article-title":"Clinical aspects of autoimmune rheumatic diseases","volume":"382","author":"Goldblatt F.","year":"2013","unstructured":"Goldblatt F. and O'Neill S.G.: Clinical aspects of autoimmune rheumatic diseases. Lancet 2013; 382: 797.","journal-title":"Lancet"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103236"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"e_1_3_5_5_2","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou M.","year":"2020","unstructured":"Kiriakidou M. and Ching C.L.: Systemic lupus erythematosus. Ann Intern Med 2020; 172. p. Itc81-itc96.","journal-title":"Ann Intern Med"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.autrev.2011.10.020","article-title":"Systemic lupus erythematosus one disease or many?","volume":"11","author":"Agmon-Levin N.","year":"2012","unstructured":"Agmon-Levin N. et al: Systemic lupus erythematosus one disease or many?. Autoimmun Rev 2012; 11: 593.","journal-title":"Autoimmun Rev"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.39"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/art.39809","article-title":"Post Hoc Analysis of the Phase II\/III APRIL-SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRIL","volume":"69","author":"Gordon C.","year":"2017","unstructured":"Gordon C. et al: Post Hoc Analysis of the Phase II\/III APRIL-SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRIL. Arthritis Rheuma 2017; 69: 122.","journal-title":"Arthritis Rheuma"},{"key":"e_1_3_5_9_2","article-title":"UV Radiation and Its Relation to DNA Methylation in Epidermal Cells: A Review","volume":"4","author":"de Oliveira N.F.P.","year":"2020","unstructured":"de Oliveira N.F.P., de Souza B.F. and de Castro Co\u00ealho M.: UV Radiation and Its Relation to DNA Methylation in Epidermal Cells: A Review. Epigenomes 2020; 4.","journal-title":"Epigenomes"},{"key":"e_1_3_5_10_2","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030506","article-title":"Epigenetic alterations in immune cells of systemic lupus erythematosus and therapeutic implications","volume":"11","author":"Adams D.E.","year":"2022","unstructured":"Adams D.E. and Shao W.H.: Epigenetic alterations in immune cells of systemic lupus erythematosus and therapeutic implications. Cells 2022; 11.","journal-title":"Cells"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40180"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-00948-y"},{"key":"e_1_3_5_13_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang Y.Z.","year":"2014","unstructured":"Zhang Y.Z. and Li Y.Y.: Inflammatory bowel disease: pathogenesis. World J Gastroenterol 2014; 20: 91.","journal-title":"World J Gastroenterol"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.07.013"},{"key":"e_1_3_5_15_2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90002-I","article-title":"Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Th\u00e9rapeutique des Affections Inflammatoires Digestives.","volume":"98","author":"Modigliani R.","year":"1990","unstructured":"Modigliani R. et al: Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Th\u00e9rapeutique des Affections Inflammatoires Digestives.. Gastroenterology 1990; 98: 811.","journal-title":"Gastroenterology"},{"key":"e_1_3_5_16_2","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1111\/j.1572-0241.2007.01474.x","article-title":"Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease","volume":"102","author":"Turner D.","year":"2007","unstructured":"Turner D. et al: Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease. Am J Gastroenterol 2007; 102: 2804. quiz 2803, 2813.","journal-title":"Am J Gastroenterol"},{"key":"e_1_3_5_17_2","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2007.09.002","article-title":"Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study","volume":"5","author":"Solberg I.C.","year":"2007","unstructured":"Solberg I.C. et al: Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007; 5: 1430.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60008-8"},{"key":"e_1_3_5_19_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nyas.13846","article-title":"Precision medicine for multiple sclerosis promotes preventative medicine","volume":"1420","author":"Hansen M.R.","year":"2018","unstructured":"Hansen M.R. and Okuda D.T.: Precision medicine for multiple sclerosis promotes preventative medicine. Ann N Y Acad Sci 2018; 1420: 62.","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08798-2"},{"key":"e_1_3_5_21_2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13075-022-02904-9","article-title":"Synoviocytes and skin fibroblasts show opposite effects on IL-23 production and IL-23 receptor expression during cell interactions with immune cells","volume":"24","author":"Noack M.","year":"2022","unstructured":"Noack M. and Miossec P.: Synoviocytes and skin fibroblasts show opposite effects on IL-23 production and IL-23 receptor expression during cell interactions with immune cells. Arthritis Res Ther 2022; 24: 220.","journal-title":"Arthritis Res Ther"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40653"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases","volume":"73","author":"Barturen G.","year":"2021","unstructured":"Barturen G. et al: Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases. Arthritis Rheuma 2021; 73: 1073.","journal-title":"Arthritis Rheuma"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102919"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq7991"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00457-9"},{"key":"e_1_3_5_27_2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin F.D.","year":"1996","unstructured":"Lublin F.D. and Reingold S.C.: Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907.","journal-title":"Neurology"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000560"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf235"},{"key":"e_1_3_5_30_2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1352458513476563","article-title":"Relapsing-remitting and primary progressive MS have the same cause(s)--the neuropathologist's view: 2","volume":"19","author":"Kuhlmann T.","year":"2013","unstructured":"Kuhlmann T.: Relapsing-remitting and primary progressive MS have the same cause(s)--the neuropathologist's view: 2. Mult Scler 2013; 19: 268.","journal-title":"Mult Scler"},{"key":"e_1_3_5_31_2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/1352458512474091","article-title":"Relapsing-remitting and primary progressive MS have the same cause(s)--the neuropathologist's view: 1","volume":"19","author":"Lassmann H.","year":"2013","unstructured":"Lassmann H.: Relapsing-remitting and primary progressive MS have the same cause(s)--the neuropathologist's view: 1. Mult Scler 2013; 19: 266.","journal-title":"Mult Scler"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1818-y"},{"key":"e_1_3_5_33_2","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/brain\/awp106","article-title":"Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease","volume":"132","author":"Tallantyre E.C.","year":"2009","unstructured":"Tallantyre E.C. et al: Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. Brain 2009; 132: 1190.","journal-title":"Brain"},{"key":"e_1_3_5_34_2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1212\/WNL.52.4.839","article-title":"Primary and transitional progressive MS: a clinical and MRI cross-sectional study","volume":"52","author":"Stevenson V.L.","year":"1999","unstructured":"Stevenson V.L. et al: Primary and transitional progressive MS: a clinical and MRI cross-sectional study. Neurology 1999; 52: 839.","journal-title":"Neurology"},{"key":"e_1_3_5_35_2","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200025","article-title":"Toward precision phenotyping of multiple sclerosis","volume":"9","author":"Pitt D.","year":"2022","unstructured":"Pitt D. et al: Toward precision phenotyping of multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 2022; 9.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"e_1_3_5_36_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005792-197809000-00001","article-title":"Renal involvement in systemic lupud erythematosus (SLE): a study of 56 patients emphasizing histologic classification","volume":"57","author":"Appel G.B.","year":"1978","unstructured":"Appel G.B. et al: Renal involvement in systemic lupud erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Med (Baltim) 1978; 57: 371.","journal-title":"Med (Baltim)"},{"key":"e_1_3_5_37_2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0031-3025(16)35204-7","article-title":"Renal disease: classification and atlas of glomerular diseases","volume":"28","author":"Painter D.M.","year":"1996","unstructured":"Painter D.M.: Renal disease: classification and atlas of glomerular diseases. Pathology 1996; 28: 215.","journal-title":"Pathology"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00443.x"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023"},{"key":"e_1_3_5_40_2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: clinical implications of pathophysiologic subtypes","volume":"13","author":"Yu F.","year":"2017","unstructured":"Yu F. et al: Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol 2017; 13: 483.","journal-title":"Nat Rev Nephrol"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.008"},{"key":"e_1_3_5_42_2","doi-asserted-by":"crossref","first-page":"6660164","DOI":"10.1155\/2021\/6660164","article-title":"Blood Genomics identifies three subtypes of systemic lupus erythematosus: \"IFN-High,\" \"NE-High,\" and \"Mixed\"","volume":"2021","author":"Cui M.","year":"2021","unstructured":"Cui M. et al: Blood Genomics identifies three subtypes of systemic lupus erythematosus: \"IFN-High,\" \"NE-High,\" and \"Mixed\". Mediat Inflamm 2021; 2021: 6660164.","journal-title":"Mediat Inflamm"},{"key":"e_1_3_5_43_2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12920-022-01306-9","article-title":"Identification of biomarkers related to neutrophils and two molecular subtypes of systemic lupus erythematosus","volume":"15","author":"Li H.","year":"2022","unstructured":"Li H. and Yang P.: Identification of biomarkers related to neutrophils and two molecular subtypes of systemic lupus erythematosus. BMC Med Genom 2022; 15: 162.","journal-title":"BMC Med Genom"},{"key":"e_1_3_5_44_2","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac332","article-title":"Scoring personalized molecular portraits identify Systemic Lupus Erythematosus subtypes and predict individualized drug responses, symptomatology and disease progression","volume":"23","author":"Toro-Dom\u00ednguez D.","year":"2022","unstructured":"Toro-Dom\u00ednguez D. et al: Scoring personalized molecular portraits identify Systemic Lupus Erythematosus subtypes and predict individualized drug responses, symptomatology and disease progression. Brief Bioinform 2022; 23.","journal-title":"Brief Bioinform"},{"key":"e_1_3_5_45_2","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf1970","article-title":"Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus","volume":"376","author":"Perez R.K.","year":"2022","unstructured":"Perez R.K. et al: Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus. Science 2022; 376. p. eabf1970.","journal-title":"Science"},{"key":"e_1_3_5_46_2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/art.40428","article-title":"Identification of Three Rheumatoid Arthritis Disease Subtypes by Machine Learning Integration of Synovial Histologic Features and RNA Sequencing Data","volume":"70","author":"Orange D.E.","year":"2018","unstructured":"Orange D.E. et al: Identification of Three Rheumatoid Arthritis Disease Subtypes by Machine Learning Integration of Synovial Histologic Features and RNA Sequencing Data. Arthritis Rheuma 2018; 70: 690.","journal-title":"Arthritis Rheuma"},{"key":"e_1_3_5_47_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2019.03.002","article-title":"Compendium of synovial signatures identifies pathologic characteristics for predicting treatment response in rheumatoid arthritis patients","volume":"202","author":"Kim K.J.","year":"2019","unstructured":"Kim K.J. et al: Compendium of synovial signatures identifies pathologic characteristics for predicting treatment response in rheumatoid arthritis patients. Clin Immunol 2019; 202: 1.","journal-title":"Clin Immunol"},{"key":"e_1_3_5_48_2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004186","article-title":"An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity","volume":"4","author":"Ottoboni L.","year":"2012","unstructured":"Ottoboni L. et al: An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity. Sci Transl Med 2012; 4. 153ra131.","journal-title":"Sci Transl Med"},{"key":"e_1_3_5_49_2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder P.","year":"2008","unstructured":"Langfelder P. and Horvath S.: WGCNA: an R package for weighted correlation network analysis. BMC Bioinforma 2008; 9: 559.","journal-title":"BMC Bioinforma"},{"key":"e_1_3_5_50_2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/1467-9868.00293","article-title":"Estimating the Number of Clusters in a Data Set Via the Gap Statistic","volume":"63","author":"Tibshirani R.","year":"2001","unstructured":"Tibshirani R., Walther G. and Hastie T.: Estimating the Number of Clusters in a Data Set Via the Gap Statistic. J R Stat Soc Ser B 2001; 63: 411.","journal-title":"J R Stat Soc Ser B"},{"key":"e_1_3_5_51_2","doi-asserted-by":"crossref","unstructured":"Kaufman L. and P. Rousseeuw Finding Groups in Data: An Introduction To Cluster Analysis. 1990.","DOI":"10.1002\/9780470316801"},{"key":"e_1_3_5_52_2","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v061.i06","article-title":"NbClust: an R Package for Determining the Relevant Number of Clusters in a Data Set","volume":"61","author":"Charrad M.","year":"2014","unstructured":"Charrad M. et al: NbClust: an R Package for Determining the Relevant Number of Clusters in a Data Set. J Stat Softw 2014; 61. p. 1 - 36.","journal-title":"J Stat Softw"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/bmsp.12136"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.32614\/RJ-2016-021"},{"key":"e_1_3_5_56_2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1471-2105-11-367","article-title":"A flexible R package for nonnegative matrix factorization","volume":"11","author":"Gaujoux R.","year":"2010","unstructured":"Gaujoux R. and Seoighe C.: A flexible R package for nonnegative matrix factorization. BMC Bioinforma 2010; 11: 367.","journal-title":"BMC Bioinforma"},{"key":"e_1_3_5_57_2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/bib\/bbz116","article-title":"CrossICC: iterative consensus clustering of cross-platform gene expression data without adjusting batch effect","volume":"21","author":"Zhao Q.","year":"2020","unstructured":"Zhao Q. et al: CrossICC: iterative consensus clustering of cross-platform gene expression data without adjusting batch effect. Brief Bioinform 2020; 21: 1818.","journal-title":"Brief Bioinform"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr406"},{"key":"e_1_3_5_59_2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12967-023-04326-w","article-title":"A precise molecular subtyping of ulcerative colitis reveals the immune heterogeneity and predicts clinical drug responses","volume":"21","author":"Mo S.","year":"2023","unstructured":"Mo S. et al: A precise molecular subtyping of ulcerative colitis reveals the immune heterogeneity and predicts clinical drug responses. J Transl Med 2023; 21: 466.","journal-title":"J Transl Med"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"e_1_3_5_61_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann S.","year":"2013","unstructured":"H\u00e4nzelmann S., Castelo R. and Guinney J.: GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma 2013; 14: 7.","journal-title":"BMC Bioinforma"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0301-7_7"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687975"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6364324"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8"},{"key":"e_1_3_5_66_2","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1093\/rheumatology\/keaa751","article-title":"Deep phenotyping of synovial molecular signatures by integrative systems analysis in rheumatoid arthritis","volume":"60","author":"Jung S.M.","year":"2021","unstructured":"Jung S.M., Park K.S. and Kim K.J.: Deep phenotyping of synovial molecular signatures by integrative systems analysis in rheumatoid arthritis. Rheumatol (Oxf) 2021; 60: 3420.","journal-title":"Rheumatol (Oxf)"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.06.049"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.08.002"},{"key":"e_1_3_5_69_2","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky1079","article-title":"The BioGRID interaction database: 2019 update","volume":"47","author":"Oughtred R.","year":"2019","unstructured":"Oughtred R. et al: The BioGRID interaction database: 2019 update. Nucleic Acids Res 2019; 47. p. D529-d541.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_5_70_2","doi-asserted-by":"crossref","first-page":"D767","DOI":"10.1093\/nar\/gkn892","article-title":"Human protein reference database--2009 update","volume":"37","author":"Keshava Prasad T.S.","year":"2009","unstructured":"Keshava Prasad T.S. et al: Human protein reference database--2009 update. Nucleic Acids Res 2009; 37: D767.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr1088"},{"key":"e_1_3_5_72_2","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx1132","article-title":"The Reactome Pathway Knowledgebase","volume":"46","author":"Fabregat A.","year":"2018","unstructured":"Fabregat A. et al: The Reactome Pathway Knowledgebase. Nucleic Acids Res 2018; 46. p. D649-d655.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_5_73_2","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab835","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk D.","year":"2021","unstructured":"Szklarczyk D. et al: The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 2021; 49. p. D605-d612.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.4530"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy215"},{"key":"e_1_3_5_76_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08804-7"},{"key":"e_1_3_5_77_2","doi-asserted-by":"crossref","first-page":"1095098","DOI":"10.3389\/fimmu.2023.1095098","article-title":"Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer","volume":"14","author":"Zhang C.","year":"2023","unstructured":"Zhang C. et al: Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer. Front Immunol 2023; 14: 1095098.","journal-title":"Front Immunol"},{"key":"e_1_3_5_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007"},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.003"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8516-1"},{"key":"e_1_3_5_81_2","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-8-S4-S11"},{"key":"e_1_3_5_82_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz447"},{"key":"e_1_3_5_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.05.012"},{"key":"e_1_3_5_84_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt660"},{"key":"e_1_3_5_85_2","doi-asserted-by":"crossref","unstructured":"Gene Ontology Consortium: going forward. Nucleic Acids Res 2015. 43(Database issue): p. D1049-D1056.","DOI":"10.1093\/nar\/gku1179"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw377"},{"key":"e_1_3_5_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337"},{"key":"e_1_3_5_88_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.27"},{"key":"e_1_3_5_89_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.124370.111"},{"key":"e_1_3_5_90_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2008.211"},{"key":"e_1_3_5_91_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1"},{"key":"e_1_3_5_92_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki078"},{"key":"e_1_3_5_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2020.10.014"},{"key":"e_1_3_5_94_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103477","article-title":"Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses","volume":"70","author":"Deng Y.","year":"2021","unstructured":"Deng Y. et al: Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses. EBioMedicine 2021; 70: 103477.","journal-title":"EBioMedicine"},{"key":"e_1_3_5_95_2","first-page":"181","article-title":"An overview of lipid abnormalities in patients with inflammatory bowel disease","volume":"24","author":"Agouridis A.P.","year":"2011","unstructured":"Agouridis A.P., Elisaf M. and Milionis H.J.: An overview of lipid abnormalities in patients with inflammatory bowel disease. Ann Gastroenterol 2011; 24: 181.","journal-title":"Ann Gastroenterol"},{"key":"e_1_3_5_96_2","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1177\/09612033211028653","article-title":"10 Years of belimumab experience: What have we learnt?","volume":"30","author":"Levy R.A.","year":"2021","unstructured":"Levy R.A. et al: 10 Years of belimumab experience: What have we learnt?. Lupus 2021; 30: 1705.","journal-title":"Lupus"},{"key":"e_1_3_5_97_2","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s40265-021-01591-1","article-title":"Telitacicept: First Approval","volume":"81","author":"Dhillon S.","year":"2021","unstructured":"Dhillon S.: Telitacicept: First Approval. Drugs 2021; 81: 1671.","journal-title":"Drugs"},{"key":"e_1_3_5_98_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645478","article-title":"Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE","volume":"12","author":"Humbel M.","year":"2021","unstructured":"Humbel M. et al: Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE. Front Immunol 2021; 12: 645478.","journal-title":"Front Immunol"},{"key":"e_1_3_5_99_2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/eji.201041354","article-title":"Plasma cells in systemic lupus erythematosus: the long and short of it all","volume":"41","author":"Liu Z.","year":"2011","unstructured":"Liu Z., Zou Y. and Davidson A.: Plasma cells in systemic lupus erythematosus: the long and short of it all. Eur J Immunol 2011; 41: 588.","journal-title":"Eur J Immunol"},{"key":"e_1_3_5_100_2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41584-020-00519-5","article-title":"IL-17 sustains plasma cells in SLE","volume":"16","author":"Clarke J.","year":"2020","unstructured":"Clarke J.: IL-17 sustains plasma cells in SLE. Nat Rev Rheuma 2020; 16: 666.","journal-title":"Nat Rev Rheuma"},{"key":"e_1_3_5_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.08.010"},{"key":"e_1_3_5_102_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.07.042"},{"key":"e_1_3_5_103_2","doi-asserted-by":"crossref","first-page":"1145070","DOI":"10.3389\/fimmu.2023.1145070","article-title":"Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine","volume":"14","author":"Ning L.","year":"2023","unstructured":"Ning L. et al: Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine. Front Immunol 2023; 14: 1145070.","journal-title":"Front Immunol"},{"key":"e_1_3_5_104_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312518"},{"key":"e_1_3_5_105_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R036012"},{"key":"e_1_3_5_106_2","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/ibd.21560","article-title":"New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease","volume":"17","author":"Shores D.R.","year":"2011","unstructured":"Shores D.R. et al: New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 2192.","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_3_5_107_2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fimmu.2020.00104","article-title":"The Imbalance of Circulating Follicular Helper T Cells and Follicular Regulatory T Cells Is Associated With Disease Activity in Patients With Ulcerative Colitis","volume":"11","author":"Long Y.","year":"2020","unstructured":"Long Y. et al: The Imbalance of Circulating Follicular Helper T Cells and Follicular Regulatory T Cells Is Associated With Disease Activity in Patients With Ulcerative Colitis. Front Immunol 2020; 11: 104.","journal-title":"Front Immunol"},{"key":"e_1_3_5_108_2","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13485"},{"key":"e_1_3_5_109_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6108"},{"key":"e_1_3_5_110_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003296","article-title":"Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: a longitudinal cohort study in the Netherlands","volume":"17","author":"Matthijssen X.M.E.","year":"2020","unstructured":"Matthijssen X.M.E. et al: Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: a longitudinal cohort study in the Netherlands. PLoS Med 2020; 17: e1003296.","journal-title":"PLoS Med"},{"key":"e_1_3_5_111_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1263-7"},{"key":"e_1_3_5_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109130"},{"key":"e_1_3_5_113_2","doi-asserted-by":"publisher","DOI":"10.1080\/10409238.2016.1215288"},{"key":"e_1_3_5_114_2","first-page":"355","article-title":"Altered aortic protease and antiprotease activity in patients with ruptured abdominal aortic aneurysms","volume":"164","author":"Cohen J.R.","year":"1987","unstructured":"Cohen J.R. et al: Altered aortic protease and antiprotease activity in patients with ruptured abdominal aortic aneurysms. Surg Gynecol Obstet 1987; 164: 355.","journal-title":"Surg Gynecol Obstet"},{"key":"e_1_3_5_115_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400724"},{"key":"e_1_3_5_116_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri3399"},{"key":"e_1_3_5_117_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2014.05.004"},{"key":"e_1_3_5_118_2","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2011.13"},{"key":"e_1_3_5_119_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0522"},{"key":"e_1_3_5_120_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060868","article-title":"Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis","volume":"17","author":"Pittayapruek P.","year":"2016","unstructured":"Pittayapruek P. et al: Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis. Int J Mol Sci 2016; 17.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_5_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102736"},{"key":"e_1_3_5_122_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102400","article-title":"ANA as an entry criterion for the classification of SLE","volume":"18","author":"Pisetsky D.S.","year":"2019","unstructured":"Pisetsky D.S., Bossuyt X. and Meroni P.L.: ANA as an entry criterion for the classification of SLE. Autoimmun Rev 2019; 18: 102400.","journal-title":"Autoimmun Rev"},{"key":"e_1_3_5_123_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954706","article-title":"IFN-\u03b3, should not be ignored in SLE.","volume":"13","author":"Liu W.","year":"2022","unstructured":"Liu W., Zhang S. and Wang J.: IFN-\u03b3, should not be ignored in SLE.. Front Immunol 2022; 13: 954706.","journal-title":"Front Immunol"},{"key":"e_1_3_5_124_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.10.010"},{"key":"e_1_3_5_125_2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/jlb.66.3.502","article-title":"Transcriptional control of the human MCP-2 gene promoter by IFN-gamma and IL-1beta in connective tissue cells.","volume":"66","author":"Van Coillie E.","year":"1999","unstructured":"Van Coillie E. et al: Transcriptional control of the human MCP-2 gene promoter by IFN-gamma and IL-1beta in connective tissue cells.. J Leukoc Biol 1999; 66: 502.","journal-title":"J Leukoc Biol"},{"key":"e_1_3_5_126_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.554725","article-title":"Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model","volume":"11","author":"Tumurkhuu G.","year":"2020","unstructured":"Tumurkhuu G. et al: Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model. Front Immunol 2020; 11: 554725.","journal-title":"Front Immunol"},{"key":"e_1_3_5_127_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00793-5"},{"key":"e_1_3_5_128_2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.joca.2007.02.005","article-title":"TGF-beta and osteoarthritis.","volume":"15","author":"Blaney Davidson E.N.","year":"2007","unstructured":"Blaney Davidson E.N., van der Kraan P.M. and van den Berg W.B.: TGF-beta and osteoarthritis.. Osteoarthr Cartil 2007; 15: 597.","journal-title":"Osteoarthr Cartil"},{"key":"e_1_3_5_129_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3143"},{"key":"e_1_3_5_130_2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41467-023-35801-z","article-title":"TGF\u03b21(+)CCR5(+) neutrophil subset increases in bone marrow and causes age-related osteoporosis in male mice.","volume":"14","author":"Li J.","year":"2023","unstructured":"Li J. et al: TGF\u03b21(+)CCR5(+) neutrophil subset increases in bone marrow and causes age-related osteoporosis in male mice.. Nat Commun 2023; 14: 159.","journal-title":"Nat Commun"},{"key":"e_1_3_5_131_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110941"},{"key":"e_1_3_5_132_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03376.x"},{"key":"e_1_3_5_133_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2008.05.001"},{"key":"e_1_3_5_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.06.017"},{"key":"e_1_3_5_135_2","first-page":"1097","article-title":"International cooperation to collect obstetric data","volume":"101","author":"Lamp\u00e9 L.","year":"1979","unstructured":"Lamp\u00e9 L. et al: International cooperation to collect obstetric data. Zent Gynakol 1979; 101: 1097.","journal-title":"Zent Gynakol"},{"key":"e_1_3_5_136_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2011.02.003","article-title":"IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer","volume":"22","author":"Neurath M.F.","year":"2011","unstructured":"Neurath M.F. and Finotto S.: IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev 2011; 22: 83.","journal-title":"Cytokine Growth Factor Rev"},{"key":"e_1_3_5_137_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri3581"},{"key":"e_1_3_5_138_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0701-9"},{"key":"e_1_3_5_139_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.267"},{"key":"e_1_3_5_140_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100977"},{"key":"e_1_3_5_141_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-051113-024537"},{"key":"e_1_3_5_142_2","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22464","article-title":"Paroxetine modulates immune responses by activating a JAK2\/STAT3 signaling pathway","volume":"34","author":"Kabiri M.","year":"2020","unstructured":"Kabiri M. et al: Paroxetine modulates immune responses by activating a JAK2\/STAT3 signaling pathway. J Biochem Mol Toxicol 2020; 34: e22464.","journal-title":"J Biochem Mol Toxicol"},{"key":"e_1_3_5_143_2","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.4049\/jimmunol.1002776","article-title":"Generation of human regulatory gammadelta T cells by TCRgammadelta stimulation in the presence of TGF-beta and their involvement in the pathogenesis of systemic lupus erythematosus","volume":"186","author":"Li X.","year":"2011","unstructured":"Li X. et al: Generation of human regulatory gammadelta T cells by TCRgammadelta stimulation in the presence of TGF-beta and their involvement in the pathogenesis of systemic lupus erythematosus. J Immunol 2011; 186: 6693.","journal-title":"J Immunol"},{"key":"e_1_3_5_144_2","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/ar2217","article-title":"Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.","volume":"9","author":"Pohlers D.","year":"2007","unstructured":"Pohlers D. et al: Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.. Arthritis Res Ther 2007; 9: R59.","journal-title":"Arthritis Res Ther"},{"key":"e_1_3_5_145_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.03.007"},{"key":"e_1_3_5_146_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120004","article-title":"Glucocorticoids for therapeutic immunosuppression: clinical pearls for the practicing neurologist","volume":"430","author":"Galati A.","year":"2021","unstructured":"Galati A. et al: Glucocorticoids for therapeutic immunosuppression: clinical pearls for the practicing neurologist. J Neurol Sci 2021; 430: 120004.","journal-title":"J Neurol Sci"},{"key":"e_1_3_5_147_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.01.062","article-title":"Prevention and management of glucocorticoid-induced side effects: a comprehensive review: A review of glucocorticoid pharmacology and bone health","volume":"76","author":"Caplan A.","year":"2017","unstructured":"Caplan A. et al: Prevention and management of glucocorticoid-induced side effects: a comprehensive review: A review of glucocorticoid pharmacology and bone health. J Am Acad Dermatol 2017; 76: 1.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_5_148_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00430-003-0210-1","article-title":"Enhancement of antimicrobial effects by glucocorticoids","volume":"194","author":"T\u00fcrck J.","year":"2005","unstructured":"T\u00fcrck J. et al: Enhancement of antimicrobial effects by glucocorticoids. Med Microbiol Immunol 2005; 194: 47.","journal-title":"Med Microbiol Immunol"},{"key":"e_1_3_5_149_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61354-2"},{"key":"e_1_3_5_150_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00634-6"},{"key":"e_1_3_5_151_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxu102"},{"key":"e_1_3_5_152_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms130911718"},{"key":"e_1_3_5_153_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12920-023-01702-9","article-title":"Identifying functional subtypes of IgA nephropathy based on three machine learning algorithms and WGCNA","volume":"17","author":"Ren H.","year":"2024","unstructured":"Ren H. et al: Identifying functional subtypes of IgA nephropathy based on three machine learning algorithms and WGCNA. BMC Med Genom 2024; 17: 61.","journal-title":"BMC Med Genom"},{"key":"e_1_3_5_154_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899372","article-title":"Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes","volume":"13","author":"Frazzei G.","year":"2022","unstructured":"Frazzei G. et al: Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes. Front Immunol 2022; 13: 899372.","journal-title":"Front Immunol"},{"key":"e_1_3_5_155_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1109"},{"key":"e_1_3_5_156_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-01091-3"},{"key":"e_1_3_5_157_2","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1038\/s41467-022-34271-z","article-title":"De novo analysis of bulk RNA-seq data at spatially resolved single-cell resolution","volume":"13","author":"Liao J.","year":"2022","unstructured":"Liao J. et al: De novo analysis of bulk RNA-seq data at spatially resolved single-cell resolution. Nat Commun 2022; 13: 6498.","journal-title":"Nat Commun"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037024000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037024000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2024.03.026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:51:15Z","timestamp":1781639475000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2024.03.026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":156,"alternative-id":["10.1016\/j.csbj.2024.03.026"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2024.03.026","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The molecular subtypes of autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2024.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}